28.02.2020 14:15:22

PDL BioPharma Enters Cooperation Agreement With Engine Capital - Quick Facts

(RTTNews) - PDL BioPharma, Inc. (PDLI) said Alan Bazaar will join the company's Board as a Class III director serving until 2022 Annual Meeting of Stockholders. The appointment of new independent director is under a cooperation agreement with Engine Capital Management LP, which owns approximately 5.5% of the company's outstanding shares. The company has also agreed to form a Cost Committee of the Board, chaired by Bazaar, to oversee cost reduction initiatives.

Bazaar is currently CEO of Hollow Brook Wealth Management and Chairman of the board of Wireless Telecom Group, Inc.

Nachrichten zu PDL BioPharma Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu PDL BioPharma Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!